• Explore /
  • Poster
  • / Association of disease progression on ibrutinib therapy with the acquisition of resistance mutations: A single-center experience of 267 patients.

Association of disease progression on ibrutinib therapy with the acquisition of resistance mutations: A single-center experience of 267 patients.

Abstract Poster

Authors

null

Jennifer Ann Woyach

The Ohio State University, Columbus, OH

Jennifer Ann Woyach , Amy S. Ruppert , Gerard Lozanski , Arletta Lozanski , Nyla A. Heerema , Weiqiang Zhao , Lynne Abruzzo , Amber Gordon , Jeffrey Alan Jones , Joseph M. Flynn , Samantha Mary Jaglowski , Leslie A. Andritsos , Farrukh Awan , Kristie A. Blum , Michael R. Grever , Amy J. Johnson , John C. Byrd , Kami J. Maddocks

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Leukemia, Myelodysplasia, and Transplantation

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Leukemia

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 7010)

DOI

10.1200/jco.2014.32.15_suppl.7010

Abstract #

7010

Poster Bd #

2

Abstract Disclosures

Similar Posters

First Author: William G. Wierda

First Author: Sean David Reiff

First Author: John C. Byrd

First Author: Susan Mary O'Brien